AGA - aspartylglucosaminidase Gene

Homo sapiens

Also known as GA; AGU; ASRG

Gene ID: 175 | Gene type: protein coding

About AGA

Cytogenetic location: 4q34.3 Genomic coordinates (GRCh38): 4:177,430,774-177,442,437 (from NCBI)

This gene has 6 transcripts (splice variants), 201 orthologues, 2 paralogues and is associated with 3 phenotypes. Ubiquitous expression in thyroid (RPKM 10.5), testis (RPKM 10.0) and 25 other tissues.

Summary

This gene encodes a member of the N-terminal nucleophile (Ntn) hydrolase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta chains that comprise the mature Enzyme. This Enzyme is involved in the catabolism of N-linked oligosaccharides of glycoproteins. It cleaves asparagine from N-acetylglucosamines as one of the final steps in the lysosomal breakdown of glycoproteins. Mutations in this gene are associated with the lysosomal storage disease aspartylglycosaminuria that results in progressive neurodegeneration. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is subject to proteolytic processing. [provided by RefSeq, Nov 2015]

AGA Products(2)

mRNA	Protein	Name
NM_000027.4	NP_000018.2	N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase isoform 1 preproprotein
NM_001171988.2	NP_001165459.1	N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase isoform 2 precursor

AGA Protein Structure

Asparaginase_2

0
100
200
300
346 a.a.

Protein Preferred Names

Protein Names

N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase

N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase

Recombinant AGA Proteins

Cat. No.	Product Name	Accession	Purity
HY-P76737	AGA/Aspartylglucosaminidase Protein, Human (HEK293, His)	P20933 (S24-I346)	≥95%

Related Diseases

Diseases

Alias

Aspartylglucosaminuria

Aspartylglycosaminuria	Glycosylasparaginase Deficiency
Aspartylglucosaminidase Deficiency	Aga Deficiency
AGU	Aspartylglucosamidase Deficiency
Glycoasparaginase	Aspartylglucosamidase Deficiency
Hyperammonemia, Type Iii

Lysosomal Storage Disease

Lysosomal Storage Diseases	Disorder Of Lysosomal Enzyme
Inborn Lysosomal Enzyme Disorder	Lysosomal Storage Metabolism Disorder
Lysosomal Storage Disorder

Fabry Disease

Alpha-Galactosidase A Deficiency	Anderson-Fabry Disease
Angiokeratoma Corporis Diffusum	Ceramide Trihexosidase Deficiency
Fabry Disease, Cardiac Variant	Fabry'S Disease
Hereditary Dystopic Lipidosis	Gla Deficiency
FD	Alpha Galactosidase Deficiency
Deficiency Of Melibiase	Angiokeratoma, Diffuse
Angiokeratoma Diffuse	Diffuse Angiokeratoma

Tinea Favosa

Favus

Diseases	Alias
Waldenstroem'S Macroglobulinemia	Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma

Related Agents

Approval

Bioactive Molecules (1)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-132609	Patisiran sodium		96.72%	Unkown

Clinical Phase

Bioactive Molecules (5)

Cat. No.	Product Name	Effect	Purity	Phase
HY-143230	Custirsen		98.71%	Phase 3
HY-132596	Tivanisiran	Inhibitor	/	Phase 3
HY-147412	Ultevursen		/	Phase 3
HY-150724	ODN 1018	Agonist	96.23%	Phase 2
HY-145726	ISIS 104838	Inhibitor	93.70%	Phase 2

Pre-clinical Phase

Bioactive Molecules (2)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-118528A	TP0427736 hydrochloride	Inhibitor	99.22%	Unkown
HY-RS00436	AGA Human Pre-designed siRNA Set A		/	Unkown

Orthologs Information

Species	Symbol	Source	ID
Mus musculus	AGA	MGD	MGI:104873
Macaca mulatta	AGA	VGNC	VGNC:69742
Bos taurus	AGA	VGNC	VGNC:25719
Felis catus	AGA	VGNC	VGNC:59673
Canis familiaris	AGA	VGNC	VGNC:37694
Rattus norvegicus	AGA	RGD	RGD:1309646
Others	AGA	NCBI

Name
Email *

	Sorry, but the email address you supplied was invalid.